Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 1, 2006, Pages 36-39

  Yin, Zheng ^a   Patel, Sejal J ^a   Wang, Wei Ling ^a   Wang, Gang ^a   Chan, Wai Ling ^a   Rao, K R Ranga ^a   Alam, Jenefer ^a   Jeyaraj, Duraiswamy A ^a   Ngew, Xinyi ^a   Patel, Viral ^a   Beer, David ^a   Lim, Siew Pheng ^a   Vasudevan, Subhash G ^a   Keller, Thomas H ^a  

^a NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

Dengue virus NS3 protease; Peptide inhibitors

Indexed keywords

ALDEHYDE DERIVATIVE; BORONIC ACID DERIVATIVE; KETONE DERIVATIVE; PROTEINASE; TETRAPEPTIDE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DENGUE VIRUS; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; NONHUMAN;

BORONIC ACIDS; CHEMISTRY, PHARMACEUTICAL; DENGUE VIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; ENZYME INHIBITORS; KETONES; KINETICS; MODELS, CHEMICAL; PEPTIDES; PROTEASE INHIBITORS; RNA HELICASES; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY; TIME FACTORS; VIRAL NONSTRUCTURAL PROTEINS;

DENGUE VIRUS;

EID: 27744581672     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.09.062     Document Type: Article

References (32)

1. M.G. Jacobs, and P.R. Young Curr. Opin. Infect. Dis. 11 1998 319
2. D.J. Gubler Clin. Microbiol. Rev. 11 1998 480
3. T.P. Monath Proc. Natl. Acad. Sci. U.S.A. 91 1994 2395
4. S. Clum, K.E. Ebner, and R. Padmanabhan J. Biol. Chem. 272 1997 30715
5. B. Falgout, R.H. Miller, and C.-J. Lai J. Virol. 67 1993 2034
6. B. Falgout, M. Pethel, Y.M. Zhang, and C.-J. Lai J. Virol. 65 1991 2467
7. L. Zhang, P.M. Mohan, and R. Padmanabhan J. Virol. 66 1992 7549
8. M. Ramachandran, Y. Sasaguri, R. Nakano, and R. Padmanabhan Methods Enzymol. 275 1996 168
9. D. Leung, K. Schroder, H. White, N.X. Fang, M.J. Stoermer, G. Abbenante, J.L. Martin, P.R. Young, and D.P. Fairlie J. Biol. Chem. 276 2001 45762;
10. S. Chanprapaph, P. Saparpakorn, C. Sangma, P. Niyomrattanakit, S. Hannongbua, C. Angsuthanasombat, and G. Katzenmeier Biochem. Biophys. Res. Commun. 330 2005 1237
11. V.K. Ganesh, N. Muller, K. Judge, C.H. Luan, R. Padmanabhan, and K.H.M. Murthy Bioorg. Med. Chem. 13 2005 257
12. J. Li, S.P. Lim, D. Beer, V. Patel, D.Y. Wen, C. Tumanut, D. Tully1, J.A. Williams, J. Jiricek, J.P. Priestle, J.L. Harris, and S.G. Vasudevan J. Biol. Chem. 280 2005 28766
13. M. Bodanszky Peptide Chemistry 2nd rev. ed. 1993 Springer Berlin (Germany)
14. T.W. Greene, and P.G.M. Wuts Protective Groups in Organic Synthesis 3rd rev ed. 1999 Wiley New York
15. J.M. Stewart, and J.D. Young Solid Phase Peptide Synthesis 2nd ed. 1984 Pierce Chemical Rockford, IL
16. S. Bajusz, E. Szell, D. Bagdy, E. Barabas, G. Horvath, M. Dioszegi, Z. Fittler, G. Szabo, A. Juhasz, E. Tomori, and G. Szilagyi J. Med. Chem. 33 1990 1729
17. Webb, T. R.; Miller, T. A.; Vlasuk, G. P. W.O Patent 9408941, 1994.
18. J.E. Semple, D.C. Rowley, T.K. Brunck, and W.C. Ripka Bioorg. Med. Chem. Lett. 7 1997 315
19. D.B. Dess, and J.C. Martin J. Org. Chem. 4 1983 4155
20. P.D. Edwards, E.F. Meyer, J. Vijayalakshmi, P.A. Tuthill, D.A. Andisik, B. Gomes, and A. Strimplerg J. Am. Chem. Soc. 114 1992 1854
21. M.J. Costanzo, S.C. Yabut, H.R. Almond, P. Andrade-Gordon, T.W. Corcoran, L. Garavilla, J.A. Kauffman, W.M. Abraham, R. Recacha, D. Chattopadhyay, and B.E. Maryanoff J. Med. Chem. 46 2003 3865
22. B. Neises, R.J. Broersma, C. Tarnus, F. Piriou, J.M. Remy, C. Lintz, E.F. Heminger, and L.W. Kutcher Bioorg. Med. Chem. 3 1995 1049
23. M.S. Bernatowicz, Y. Wu, and G.R. Matsueda Tetrahedron Lett. 34 1993 3389
24. B. Drake, M. Patek, and M. Lebi Synthesis 1994 579
25. C. Lebarbier, F. Carreaux, B. Carboni, and J.L. Boucher Bioorg. Med. Chem. Lett. 8 1998 2573
26. J. Wityak, R.A. Earl, M.M. Abelman, Y.B. Bethel, B.N. Fisher, G.S. Kauffman, C.A. Kettner, P. Ma, J.L. McMillan, L.J. Mersinger, J. Pesti, M.E. Pierce, F.W. Rankin, R.J. Chorvat, and P.N. Confalone J. Org. Chem. 60 1995 3717
27. i values were derived for inhibitors by fitting the calculated initial velocity's to a nonlinear regression curve fit using GraphPad prism software and then applying the Cheng and Prusoff relationships (1973) for competitive inhibitor.
28. M. Llinás-Brunet, M. Bailey, G. Fazal, S. Goulet, T. Halmos, S. Laplante, R. Maurice, M. Poirier, M.-A. Poupart, D. Thibeault, D. Wernic, and D. Lamarre Bioorg. Med. Chem. Lett. 8 1998 1713
29. S. Malancona, S. Colarusso, J.M. Ontoria, A. Marchetti, M. Poma, I. Stansfield, R. Laufer, A.D. Marco, M. Taliani, M. Verdirame, O. Gonzalez-Paz, V.G. Matassa, and F. Narjes Bioorg. Med. Chem. Lett. 14 2004 4575
30. S.F. Brady, J.T. Sisko, K.J. Stauffer, C.D. Colton, H. Qiu, S.D. Lewis, A.S. Ng, J.A. Shafter, M.J. Bogusky, D.F. Veber, and R.F. Nutt Bioorg. Med. Chem. 8 1995 1063
31. S. Mehdi Bioorg. Chem. 4 1993 4155
32. Z.J. Ni, and A.S. Wagman Curr. Opin. Drug Discovery Dev. 7 2004 446